GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Other Operating Expense

Yuhan (XKRX:000100) Other Operating Expense : ₩184,523 Mil (TTM As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Other Operating Expense?

Yuhan's Other Operating Expense for the three months ended in Mar. 2024 was ₩45,415 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩184,523 Mil.

Yuhan's quarterly Other Operating Expense declined from Sep. 2023 (₩52,191 Mil) to Dec. 2023 (₩47,881 Mil) and declined from Dec. 2023 (₩47,881 Mil) to Mar. 2024 (₩45,415 Mil).

Yuhan's annual Other Operating Expense declined from Dec. 2021 (₩178,865 Mil) to Dec. 2022 (₩174,674 Mil) but then increased from Dec. 2022 (₩174,674 Mil) to Dec. 2023 (₩182,369 Mil).


Yuhan Other Operating Expense Historical Data

The historical data trend for Yuhan's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Other Operating Expense Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159,033.66 176,775.12 178,865.29 174,674.03 182,368.75

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43,260.03 39,037.03 52,190.71 47,880.99 45,414.53

Yuhan Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩184,523 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yuhan Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Yuhan's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuhan (XKRX:000100) Business Description

Traded in Other Exchanges
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines